Pedro Pablo Schmidt

CEO & Founder of KA-EX I World Food Innovation Award 2026 - Best Sport Nutrition (FoodBev) I Innovator of the Year 2023 & 2025 (Global Health & Pharma) I Top 10 hottest European startups in 2023 (Startup City)

Zurich, Zurich, Switzerland

About

Founder & CEO of KA-EX, the Swiss functional beverage and food-tech company redefining recovery and stress reduction through science. Pharmaceutical scientist by training (ETH Zürich) with industry experience at Bristol-Myers Squibb and Teva. I built KA-EX from a lab concept into Switzerland’s best-selling dietary supplement and a global technology platform — powered by our patented VICAP dual-chamber system, enabling ingredients that were previously impossible in RTDs. Today KA-EX supplies thousands of elite athletes, from Formula 1 to top football clubs, and is expanding across the US and Europe. Passionate about solving complex biochemical challenges, scaling consumer brands internationally, and creating an entirely new generation of functional RTDs.

Experience

  • CEO & Founder at ph. AG (KAEX®)
    Jan 2016 - Present · 10 yrs 6 mos

    ➢ Developer of world’s first sports-recovery drink to demonstrate a statistically significant improvement in stress hormone. Noticeable boost in day-to-day energy level and positive effects on muscle growth/gains in endurance ➢ Backed by independent clinical study by world-leading scientists showing statistically significant results ➢ Top-10 best-selling "Nutritional Supplement" (of 40k products) in Switzerland ➢ Available in 30k POS around Europe (pharmacies, supermarkets, gyms, convenience stores, kiosks, vending machines, etc.) ➢ Supplier of several 1000 Pro Athletes, incl. some of the best soccer teams, pro cycling team, NFL, and many more ➢ Award Winner: "World Food Innovation Award 2026 - Best Sports Nutrition Product" (Food&Bev) ➢ Award Winner: "Innovator of the Year 2023" (Global Health & Pharma) ➢ Award Winner: "Top 10 hottest European startups in 2023" (Startup City) visit us on www.ka-ex.com

  • Advisory Board Member at CONDA.ch
    Jan 2024 - Present · 2 yrs 6 mos

  • Product Manager Oncology at Teva Pharmaceuticals
    Sep 2013 - Dec 2015 · 2 yrs 4 mos

    ➢ Lead in all marketing activities for oncology products, including biopharmaceuticals, generic products and medical devices in Switzerland ➢ Launch of various generic products & medical devices and promotional launch of a biopharmaceutical ➢ Pronounced involvement in different cross-business projects (supply, demand, portfolio management, regulatory affairs) ➢ Broad scientific and market knowledge in the field of oncology ➢ Part of the European Excellence Team for developing and sharing best practicies

  • Jr. Product Manager Virology/Immunology at Bristol-Myers Squibb
    Jan 2013 - Aug 2013 · 8 mos

    ➢ Lead in the promotion relaunch and Champion of all marketing activities of Baraclude® in Switzerland ➢ Direct reporting to BUD ➢ Adaptation and implementation of EU product strategy in Switzerland ➢ Generation of new, state-of-the art promotional material ➢ Generation of trainings material and execution of trainings workshop for Sales Representatives ➢ Close cooperation with Sales Manager during customer segmentation and tiering ➢ Generation of Budget Projections and Demand Sales Forecast

  • Corporate Sustainability & Strategy Project at Siemens Management Consulting
    Feb 2012 - Jun 2012 · 5 mos

    “Translating Sustainability Challenges into Business Opportunities for Siemens Building Technologies Division” ➢ Market research & analysis ➢ Identification of business opportunities ➢ Development of business strategies ➢ Presentation to top management of Siemens BT Division